510(k) K170147
K170147 is an FDA 510(k) premarket notification submitted by Asahi Kasei Pharma Corporation for the device "Lucica Glycated Albumin-L". The FDA issued a decision of Substantially Equivalent on Oct 12, 2017. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 12, 2017
- Date Received
- Jan 17, 2017
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Assay, Glycosylated Hemoglobin
- Device Class
- Class II
- Regulation Number
- 864.7470
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Asahi Kasei Pharma Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.